InsiderClue
Stocks · Health care · Medicinal Chemicals & Botanical Products

USANA HEALTH SCIENCES INC

USNA Clue Score33
United States Fiscal year ends January CIK 0000896264
$14.66 +0.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $14.66 −84.74% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1,006.1Operating income138.6Net income100.0EPS, diluted3.99Fiscal year 2017Revenue1,047.3 +4.1%Operating income132.5Net income62.5 −37.5%EPS, diluted2.53 −36.6%Fiscal year 2018Revenue1,189.2 +13.6%Operating income188.4Net income126.2 +101.8%EPS, diluted5.12 +102.4%Fiscal year 2019Revenue1,060.9 −10.8%Operating income146.2Net income100.5 −20.4%EPS, diluted4.41 −13.9%Fiscal year 2021Revenue1,134.6 +7.0%Operating income176.5Net income124.7 +24.0%EPS, diluted5.86 +32.9%Fiscal year 2022Revenue1,186.5 +4.6%Operating income170.2Net income116.5 −6.5%EPS, diluted5.73 −2.2%Fiscal year 2022Revenue998.6 −15.8%Operating income107.6Net income69.4 −40.5%EPS, diluted3.59 −37.3%Fiscal year 2023Revenue921.0 −7.8%Operating income93.1Net income63.8 −8.0%EPS, diluted3.30 −8.1%Fiscal year 2024Revenue854.5 −7.2%Operating income66.3Net income42.0 −34.1%EPS, diluted2.19 −33.6%Fiscal year 2026Revenue925.3 +8.3%Operating income37.4Net income10.8 −74.4%EPS, diluted0.58 −73.5%
FY2016FY2017FY2018FY2019FY2021FY2022FY2022FY2023FY2024FY2026
Revenue 1,006.1 1,047.3 1,189.2 1,060.9 1,134.6 1,186.5 998.6 921.0 854.5 925.3
Growth +4.1% +13.6% −10.8% +7.0% +4.6% −15.8% −7.8% −7.2% +8.3%
Operating income 138.6 132.5 188.4 146.2 176.5 170.2 107.6 93.1 66.3 37.4
Net income 100.0 62.5 126.2 100.5 124.7 116.5 69.4 63.8 42.0 10.8
Growth −37.5% +101.8% −20.4% +24.0% −6.5% −40.5% −8.0% −34.1% −74.4%
EPS, diluted 3.99 2.53 5.12 4.41 5.86 5.73 3.59 3.30 2.19 0.58
Growth −36.6% +102.4% −13.9% +32.9% −2.2% −37.3% −8.1% −33.6% −73.5%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin82.1%Operating margin13.8%Net margin9.9%Free cash flow margin10.4%Fiscal year 2017Gross margin82.9%Operating margin12.7%Net margin6.0%Free cash flow margin10.6%Fiscal year 2018Gross margin83.1%Operating margin15.8%Net margin10.6%Free cash flow margin11.8%Fiscal year 2019Gross margin82.3%Operating margin13.8%Net margin9.5%Free cash flow margin10.4%Fiscal year 2021Gross margin81.6%Operating margin15.6%Net margin11.0%Free cash flow margin12.8%Fiscal year 2022Gross margin81.6%Operating margin14.3%Net margin9.8%Free cash flow margin9.1%Fiscal year 2022Gross margin80.6%Operating margin10.8%Net margin6.9%Free cash flow margin9.4%Fiscal year 2023Gross margin80.8%Operating margin10.1%Net margin6.9%Free cash flow margin6.1%Fiscal year 2024Gross margin81.1%Operating margin7.8%Net margin4.9%Free cash flow margin6.0%Fiscal year 2026Gross margin78.3%Operating margin4.0%Net margin1.2%Free cash flow margin0.9%
FY2016FY2017FY2018FY2019FY2021FY2022FY2022FY2023FY2024FY2026
Gross margin 82.1% 82.9% 83.1% 82.3% 81.6% 81.6% 80.6% 80.8% 81.1% 78.3%
Operating margin 13.8% 12.7% 15.8% 13.8% 15.6% 14.3% 10.8% 10.1% 7.8% 4.0%
Net margin 9.9% 6.0% 10.6% 9.5% 11.0% 9.8% 6.9% 6.9% 4.9% 1.2%
Free cash flow margin 10.4% 10.6% 11.8% 10.4% 12.8% 9.1% 9.4% 6.1% 6.0% 0.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow136.9Capital expenditure−32.7Free cash flow104.2Buybacks−64.6Fiscal year 2017Operating cash flow123.8Capital expenditure−13.2Free cash flow110.6 +6.1%Buybacks−50.0Fiscal year 2018Operating cash flow152.1Capital expenditure−11.4Free cash flow140.7 +27.3%Buybacks−105.4Fiscal year 2019Operating cash flow126.7Capital expenditure−16.6Free cash flow110.2 −21.7%Buybacks−150.0Fiscal year 2021Operating cash flow160.4Capital expenditure−15.1Free cash flow145.3 +31.9%Buybacks−57.0Fiscal year 2022Operating cash flow121.2Capital expenditure−12.8Free cash flow108.5 −25.4%Buybacks−177.8Fiscal year 2022Operating cash flow103.9Capital expenditure−10.4Free cash flow93.5 −13.8%Buybacks−25.4Fiscal year 2023Operating cash flow70.6Capital expenditure−14.5Free cash flow56.1 −40.0%Buybacks−11.6Fiscal year 2024Operating cash flow61.0Capital expenditure−10.1Free cash flow50.9 −9.3%Buybacks−9.4Fiscal year 2026Operating cash flow22.3Capital expenditure−13.8Free cash flow8.5 −83.3%Buybacks−27.5
FY2016FY2017FY2018FY2019FY2021FY2022FY2022FY2023FY2024FY2026
Operating cash flow 136.9 123.8 152.1 126.7 160.4 121.2 103.9 70.6 61.0 22.3
Capital expenditure −32.7 −13.2 −11.4 −16.6 −15.1 −12.8 −10.4 −14.5 −10.1 −13.8
Free cash flow 104.2 110.6 140.7 110.2 145.3 108.5 93.5 56.1 50.9 8.5
Growth +6.1% +27.3% −21.7% +31.9% −25.4% −13.8% −40.0% −9.3% −83.3%
Buybacks −64.6 −50.0 −105.4 −150.0 −57.0 −177.8 −25.4 −11.6 −9.4 −27.5

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash175.8Shareholders’ equity325.3Fiscal year 2017Cash247.1Shareholders’ equity363.2Fiscal year 2018Cash214.3Shareholders’ equity391.1Fiscal year 2019Cash234.8Shareholders’ equity351.7Fiscal year 2021Cash311.9Shareholders’ equity441.7Fiscal year 2022Cash239.8Shareholders’ equity395.1Fiscal year 2022Cash288.4Shareholders’ equity434.5Fiscal year 2023Cash330.4Shareholders’ equity497.2Fiscal year 2024Cash181.8Shareholders’ equity532.1Fiscal year 2026Cash158.4Shareholders’ equity533.1
FY2016FY2017FY2018FY2019FY2021FY2022FY2022FY2023FY2024FY2026
Cash 175.8 247.1 214.3 234.8 311.9 239.8 288.4 330.4 181.8 158.4
Shareholders’ equity 325.3 363.2 391.1 351.7 441.7 395.1 434.5 497.2 532.1 533.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending January, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 30 Dec 2017 FY2018 29 Dec 2018 FY2019 28 Dec 2019 FY2021 2 Jan 2021 FY2022 1 Jan 2022 FY2022 31 Dec 2022 FY2023 30 Dec 2023 FY2024 28 Dec 2024 FY2026 3 Jan 2026
Assets
175.8 247.1 214.3 234.8 311.9 239.8 288.4 330.4 181.8 158.4
64.8 62.9 81.9 68.9 90.2 98.3 67.1 61.5 69.7 102.6
101.3 102.8 92.0 95.2 100.4 101.8 97.8 99.8 94.6 94.4
16.7 17.4 16.8 16.6 17.4 17.7 17.4 17.1 144.2 138.0
470.6 519.3 554.5 516.9 640.9 577.7 596.5 632.8 748.2 742.9
Growth +10.3% +6.8% −6.8% +24.0% −9.9% +3.3% +6.1% +18.2% −0.7%
Liabilities
n/a n/a n/a n/a n/a n/a n/a 135.6 161.9 156.6
Equity
265.4 288.1 329.5 306.1 382.8 344.6 391.6 445.2 478.9 465.7
325.3 363.2 391.1 351.7 441.7 395.1 434.5 497.2 532.1 533.1
Growth +11.7% +7.7% −10.1% +25.6% −10.5% +10.0% +14.4% +7.0% +0.2%
Per share and net cash
24.5 24.0 23.6 21.7 21.0 19.4 19.2 19.1 19.1 18.3
calc 13.29 15.12 16.60 16.24 20.99 20.37 22.62 25.99 27.91 29.16

Lines marked calc are worked out here from filed figures; point at one for how.